$CTRE
CareTrust REIT, Inc. Stock $ctre

$ctre Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024019995 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$68.89M	$63.07M
YoY Change	33.63%	24.63%
Cost Of Revenue	$255.0K	$660.0K
YoY Change	-61.25%	-31.46%
Gross Profit	$68.64M	$62.41M
YoY Change	34.86%	25.72%
Gross Profit Margin	99.63%	98.95%
Selling, General & Admin	$8.112M	$8.639M
YoY Change	32.81%	45.41%
% of Gross Profit	11.82%	13.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.88M	$13.46M
YoY Change	8.99%	9.88%
% of Gross Profit	20.22%	21.57%
Operating Expenses	$21.97M	$22.09M
YoY Change	16.72%	21.5%
Operating Profit	$46.66M	$40.32M
YoY Change	45.5%	28.16%
Interest Expense	$8.679M	$8.228M
YoY Change	-21.39%	-16.27%
% of Operating Profit	18.6%	20.41%
Other Income/Expense, Net
YoY Change
Pretax Income	$10.42M	$28.75M
YoY Change	-2252.48%	49.53%
Income Tax
% Of Pretax Income
Net Earnings	$10.76M	$28.75M
YoY Change	-2322.73%	49.51%
Net Earnings / Revenue	15.62%	45.58%
Basic Earnings Per Share	$0.07	$0.22
Diluted Earnings Per Share	$0.07	$0.22
COMMON SHARES
Basic Shares Outstanding	142.1M shares	130.5M shares
Diluted Shares Outstanding	145.3M shares	133.2M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$495.1M	$451.2M
YoY Change	43143.14%	1507.31%
Cash & Equivalents	$495.1M	$451.2M
Short-Term Investments
Other Short-Term Assets	$30.50M	$27.75M
YoY Change	117.42%	-5.99%
Inventory
Prepaid Expenses
Receivables	$1.096M	$402.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$526.7M	$479.3M
YoY Change	3284.95%	726.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.140B	$1.853B
YoY Change	26.24%	20.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$32.26M	$16.33M
YoY Change	22.49%	-27.73%
Total Long-Term Assets	$2.172B	$1.869B
YoY Change	26.18%	19.5%
TOTAL ASSETS
Total Short-Term Assets	$526.7M	$479.3M
Total Long-Term Assets	$2.172B	$1.869B
Total Assets	$2.699B	$2.348B
YoY Change	55.37%	44.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$37.11M	$35.28M
YoY Change	76.4%	45.98%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$81.83M	$76.47M
YoY Change	67.41%	46.75%
LONG-TERM LIABILITIES
Long-Term Debt	$671.1M	$595.9M
YoY Change	-23.3%	-18.35%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$671.1M	$595.9M
YoY Change	-23.3%	-18.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$81.83M	$76.47M
Total Long-Term Liabilities	$671.1M	$595.9M
Total Liabilities	$753.0M	$672.3M
YoY Change	-18.5%	-14.01%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$2.458B	$2.154B
YoY Change	97.14%	72.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.944B	$1.674B
YoY Change
Total Liabilities & Shareholders Equity	$2.699B	$2.348B
YoY Change	55.37%	44.77%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$10.76M	$28.75M
YoY Change	-2322.73%	49.51%
Depreciation, Depletion And Amortization	$13.88M	$13.46M
YoY Change	8.99%	9.88%
Cash From Operating Activities	$52.98M	$48.82M
YoY Change	66.24%	39.01%
INVESTING ACTIVITIES
Capital Expenditures	$138.9M	$67.02M
YoY Change	-21.47%	3219.32%
Acquisitions
YoY Change
Other Investing Activities	-$206.5M	-$56.22M
YoY Change	-21004.45%	-4781.43%
Cash From Investing Activities	-$345.4M	-$123.2M
YoY Change	96.44%	14966.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	336.4M	$231.1M
YoY Change	187.42%	-1290.86%
NET CHANGE
Cash From Operating Activities	52.98M	$48.82M
Cash From Investing Activities	-345.4M	-$123.2M
Cash From Financing Activities	336.4M	$231.1M
Net Change In Cash	43.96M	$156.7M
YoY Change	-263.27%	952.41%
FREE CASH FLOW
Cash From Operating Activities	$52.98M	$48.82M
Capital Expenditures	$138.9M	$67.02M
Free Cash Flow	-$85.89M	-$18.20M
YoY Change	-40.75%	-154.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	9568000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4443000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	141712165	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	141712165	shares
CY2024Q1	us-gaap	Revenues Revenues	63070000	usd
CY2023Q1	us-gaap	Revenues Revenues	50606000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13448000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	12238000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	8228000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9827000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1801000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	880000	usd
CY2024Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	2744000	usd
CY2023Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	1886000	usd
CY2024Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	660000	usd
CY2023Q1	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	963000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6838000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5061000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	33719000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	30855000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	11000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-70000	usd
CY2024Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	-612000	usd
CY2023Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments UnrealizedGainLossOnOtherRealEstateRelatedInvestments	-454000	usd
CY2024Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-601000	usd
CY2023Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-524000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	28750000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	19227000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	28746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132836000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99063000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133202000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99087000	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1418717000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	269787000	usd
CY2024Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-2483000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2120000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	41192000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	47000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	444000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	28750000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1676096000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	849373000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-1479000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	936000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.28
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	27738000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	19227000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	840319000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	28750000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	19227000	usd
CY2024Q1	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	13462000	usd
CY2023Q1	ctre	Depreciation And Amortization Including Below Market Ground Leases Excluding Amortization Of Deferred Financing Costs DepreciationAndAmortizationIncludingBelowMarketGroundLeasesExcludingAmortizationOfDeferredFinancingCosts	12252000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	614000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	609000	usd
CY2024Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	-612000	usd
CY2023Q1	ctre	Unrealized Gain Loss On Other Real Estate Related Investments Operating Cash Flows UnrealizedGainLossOnOtherRealEstateRelatedInvestmentsOperatingCashFlows	-454000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2120000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2024Q1	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	575000	usd
CY2023Q1	us-gaap	Amortization Of Below Market Lease AmortizationOfBelowMarketLease	0	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	425000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-150000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	11000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-70000	usd
CY2024Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	2744000	usd
CY2023Q1	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	1886000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	322000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-61000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1859000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-499000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48820000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	35120000	usd
CY2024Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	66619000	usd
CY2023Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	0	usd
CY2024Q1	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	398000	usd
CY2023Q1	ctre	Payments To Acquire Equipment Furniture And Fixtures And Develop Real Estate Assets PaymentsToAcquireEquipmentFurnitureAndFixturesAndDevelopRealEstateAssets	2019000	usd
CY2024Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	52165000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
CY2024Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	0	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	15143000	usd
CY2024Q1	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	4105000	usd
CY2023Q1	us-gaap	Payments For Deposits On Real Estate Acquisitions PaymentsForDepositsOnRealEstateAcquisitions	17172000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	46000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	3230000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-123241000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-818000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	269787000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-501000	usd
CY2024Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10000000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	24000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	21000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2483000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1479000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	36531000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	27409000	usd
CY2024Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	444000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	47000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	231146000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19410000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	156725000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14892000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	294448000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13178000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	451173000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28070000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	3771000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6671000	usd
CY2024Q1	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	4661000	usd
CY2023Q1	ctre	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	393000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	369000	usd
CY2024Q1	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	5000	usd
CY2023Q1	ctre	Transfer Of Preacquisition Costs To Acquired Assets TransferOfPreacquisitionCostsToAcquiredAssets	0	usd
CY2024Q1	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	1000000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	usd
CY2024Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	29	state
CY2024Q1	ctre	Number Of Preferred Equity Investment NumberOfPreferredEquityInvestment	1	investment
CY2024Q1	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	233300000	usd
CY2024Q1	us-gaap	Land Land	287607000	usd
CY2023Q4	us-gaap	Land Land	279276000	usd
CY2024Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1676474000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1620014000	usd
CY2024Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	101475000	usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	100504000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5283000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5283000	usd
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2070839000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2005077000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	451401000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	437958000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1619438000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1567119000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	156186000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	209637000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	209418000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	206337000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	204172000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	199750000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	885009000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	2070509000	usd
CY2024Q1	ctre	Period Of Option Window PeriodOfOptionWindow	P6M
CY2024Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	52934000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	46170000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	-7000	usd
CY2024Q1	ctre	Operating Lease Lease Income Amortization Of Below Market Lease Intangible OperatingLeaseLeaseIncomeAmortizationOfBelowMarketLeaseIntangible	575000	usd
CY2023Q1	ctre	Operating Lease Lease Income Amortization Of Below Market Lease Intangible OperatingLeaseLeaseIncomeAmortizationOfBelowMarketLeaseIntangible	0	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	53502000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46163000	usd
CY2024Q1	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	1500000	usd
CY2023Q1	ctre	Operating Leases Tenant Operating Expense Reimbursement OperatingLeasesTenantOperatingExpenseReimbursement	700000	usd
CY2024Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	66624000	usd
CY2024Q1	ctre	Operating Leases Anticipated Initial Annual Lease Revenues OperatingLeasesAnticipatedInitialAnnualLeaseRevenues	6025000	usd
CY2024Q1	ctre	Number Of Properties Acquired NumberOfPropertiesAcquired	4	property
CY2024Q1	ctre	Number Of Beds Or Units In Properties Acquired NumberOfBedsOrUnitsInPropertiesAcquired	320	bed
CY2024Q1	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	0	usd
CY2023Q1	ctre	Financing Receivable Principal Payments Received FinancingReceivablePrincipalPaymentsReceived	143000	usd
CY2024Q1	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	0	usd
CY2023Q1	ctre	Loan Receivable Accrued Interest LoanReceivableAccruedInterest	1000	usd
CY2024Q1	ctre	Loan Receivable Net Change LoanReceivableNetChange	0	usd
CY2023Q1	ctre	Loan Receivable Net Change LoanReceivableNetChange	-144000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	9568000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	4443000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	600000000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4127000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	595873000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	600000000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4402000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	595598000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2024Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2024-04-15
CY2024Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	41192000	usd
CY2024Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2024-03-28
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	510596	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	21.01
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	145043	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	20.89
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	35161	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	20.48
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	330392	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	21.12
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2120000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	936000	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	900000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7900000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	28746000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	19227000	usd
CY2024Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	96000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	89000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28650000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28650000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	19138000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	19138000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	132836000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99063000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133202000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99087000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	330000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	318000	shares

Files In Submission

Name	View Source	Status
0001628280-24-019995-index-headers.html	Edgar Link	pending
0001628280-24-019995-index.html	Edgar Link	pending
0001628280-24-019995.txt	Edgar Link	pending
0001628280-24-019995-xbrl.zip	Edgar Link	pending
ctre-20240331.htm	Edgar Link	pending
ctre-20240331.xsd	Edgar Link	pending
ctre20240331q1ex311.htm	Edgar Link	pending
ctre20240331q1ex312.htm	Edgar Link	pending
ctre20240331q1ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
ctre-20240331_cal.xml	Edgar Link	unprocessable
ctre-20240331_def.xml	Edgar Link	unprocessable
ctre-20240331_lab.xml	Edgar Link	unprocessable
ctre-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ctre-20240331_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CTRE
CareTrust REIT, Inc. Stock $ctre

2024 Q2 Form 10-Q Financial Statement

#000162828024019995 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE CareTrust REIT, Inc. Stock $ctre

2024 Q2 Form 10-Q Financial Statement

#000162828024019995 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CTRE
CareTrust REIT, Inc. Stock $ctre